Financing ·
On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. closed a private placement of 2,703,727 shares…
HRGNHarvard Apparatus Regenerative Technology, Inc.
On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. closed a private placement of 2,703,727 shares of common stock for an aggregate purchase price of $2,838,911 at $1.05 per share. CEO Jerry (Junli) He purchased 683,725 shares by converting and cancelling $717,911 in outstanding principal and accrued interest from bridge promissory notes issued between April and July 2026. The transaction was conducted under Section 4(a)(2) exemptions for accredited investors. Harvard Apparatus Regenerative Technology operates in the medical device industry, specifically developing regenerative medicine technologies.